Literature DB >> 9831941

Risk factors for death in patients with candidemia.

M Nucci1, A L Colombo, F Silveira, R Richtmann, R Salomão, M L Branchini, N Spector.   

Abstract

OBJECTIVE: To analyze possible risk factors for death among patients with nosocomial candidemia. To identify risk factors for death in patients with candidemia, we analyzed demographic, clinical, and microbiological data.
SETTING: Six tertiary hospitals in Brazil. PATIENTS: A cohort of 145 patients with candidemia.
DESIGN: 26 possible risk factors for death, including age, underlying disease, signs of deep-seated infection, neutropenia, number of positive blood cultures, removal of a central venous catheter, etiologic agent of the candidemia, susceptibility pattern of the isolate to amphotericin B, and antifungal treatment were evaluated by univariate stepwise logistic regression analysis.
RESULTS: Non-albicans species accounted for 63.4% of the candidemias. Risk factors for death in univariate analysis were older age, catheter retention, poor performance status, candidemia due to species other than Candida parapsilosis, hypotension, candidemia due to species other than Candida parapsilosis, and no antifungal treatment. In multivariate analysis, older age and nonremoval of a central venous catheter were the only factors associated with an increased risk for death.
CONCLUSIONS: These data suggest that patients with candidemia and a central venous catheter should have the catheter removed.

Entities:  

Mesh:

Year:  1998        PMID: 9831941     DOI: 10.1086/647743

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  33 in total

1.  Non-albicans Candida species isolated from plastic devices.

Authors:  E Dorko; M Kmet'ová; A Marossy; F Dorko; M Molokácová
Journal:  Mycopathologia       Date:  1999-12       Impact factor: 2.574

Review 2.  Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Authors:  L Ostrosky-Zeichner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

Review 4.  Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients.

Authors:  Natalie J Carter; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

5.  Nosocomial fungemia due to Exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: newly described causes of bloodstream infection.

Authors:  M Nucci; T Akiti; G Barreiros; F Silveira; S G Revankar; D A Sutton; T F Patterson
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers.

Authors:  Arnaldo L Colombo; Marcio Nucci; Benjamin J Park; Simone A Nouér; Beth Arthington-Skaggs; Daniel A da Matta; David Warnock; Juliette Morgan
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

7.  Diagnostic usefulness of differential time to positivity for catheter-related candidemia.

Authors:  Ki-Ho Park; Mi Suk Lee; Sang-Oh Lee; Sang-Ho Choi; Heungsup Sung; Mi-Na Kim; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  J Clin Microbiol       Date:  2014-05-14       Impact factor: 5.948

8.  Development and characterization of an in vivo central venous catheter Candida albicans biofilm model.

Authors:  D Andes; J Nett; P Oschel; R Albrecht; K Marchillo; A Pitula
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.

Authors:  Rana A Hajjeh; Andre N Sofair; Lee H Harrison; G Marshall Lyon; Beth A Arthington-Skaggs; Sara A Mirza; Maureen Phelan; Juliette Morgan; Wendy Lee-Yang; Meral A Ciblak; Lynette E Benjamin; Laurie Thomson Sanza; Sharon Huie; Siew Fah Yeo; Mary E Brandt; David W Warnock
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 10.  The iC3b receptor of Candida albicans and its roles in pathogenesis.

Authors:  Margaret K Hostetter
Journal:  Vaccine       Date:  2008-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.